{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-cough/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"e1226b71-f64b-5a62-81df-0219b18ce529","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 04413926-bcf8-49f2-9d9c-b971074ad7af --><h2>Changes</h2><!-- end field 04413926-bcf8-49f2-9d9c-b971074ad7af -->","summary":null,"htmlStringContent":"<!-- begin item 70865eaf-5e99-48ca-a1a5-e96980c90294 --><!-- begin field 973a8f5a-7169-478f-8f1d-bbcbeee29163 --><p><strong>April 2020 </strong>— minor update. New management scenario created to provide information regarding COVID-19. </p><p><strong>July 2015 to October 2016</strong> — reviewed. Literature searches were conducted in September 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. There have been structural changes to the topic and changes to the recommendations have been updated in line with NICE guidance <em>Care of dying adults in the last days of life </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-cough/references/\">NICE, 2015</a>]. </p><!-- end field 973a8f5a-7169-478f-8f1d-bbcbeee29163 --><!-- end item 70865eaf-5e99-48ca-a1a5-e96980c90294 -->","topic":{"id":"d321ef5c-4612-5a6b-aafc-a656ec8fb1e6","topicId":"561865b5-2a09-480f-ae63-783b229b69bf","topicName":"Palliative care - cough","slug":"palliative-care-cough","lastRevised":"Last revised in April 2020","chapters":[{"id":"bce97da8-92b8-599d-88a3-f95ee1c136d2","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ff610ad5-9e7b-56ea-8eac-bfd602137594","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a8409825-4431-5ee0-9294-3c43a9596f99","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"e1226b71-f64b-5a62-81df-0219b18ce529","slug":"changes","fullItemName":"Changes"},{"id":"3ad0995f-5610-51ce-bb35-457850cd484e","slug":"update","fullItemName":"Update"}]},{"id":"d7bb7e5e-514b-547f-9b69-4fb3327ec125","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"74afa2f6-d51b-5cbd-b460-b6e4d03732af","slug":"goals","fullItemName":"Goals"},{"id":"34cc375e-0ca3-5323-a1cd-021d11c018db","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a037a0d5-cb13-59dc-94c7-55040a012faf","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9342453d-dbf4-55fb-b5dc-50216b89f42b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bd5feaf8-f260-59ed-9474-23ad808b0e62","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"00a6af51-79f3-5510-a3e6-1f4f8c942f40","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5811a833-882d-55ab-a3f5-09d1feff4254","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2bfea1d4-d4ce-5066-af76-c1bc08c5c287","slug":"purpose-mechanism-of-cough","fullItemName":"Purpose and mechanism of cough"},{"id":"e6e866d7-040b-5653-a045-a47d96b61bda","slug":"prevalence-of-cough-in-palliative-care","fullItemName":"Prevalence of cough in palliative care"},{"id":"848fec2b-a258-59bb-99e5-11ab01a40295","slug":"causes-of-cough-in-palliative-care","fullItemName":"Causes of cough in palliative care"},{"id":"b7268bf0-d5b4-5fde-9016-68778770d8ad","slug":"complications-of-cough","fullItemName":"Complications of cough"}]},{"id":"82094bd0-c604-5bbf-acb9-8de75cf96107","fullItemName":"Management","slug":"management","subChapters":[{"id":"b6ff7bf7-561f-55f0-ad57-2373c98c25a4","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"59d61f62-958b-56b8-8aa4-2cfb39def0c1","slug":"known-cause-of-cough","fullItemName":"Scenario: Known cause of cough"},{"id":"7cb56d6a-7186-5fc1-9c6b-0f3af49e4b20","slug":"symptomatic-treatment","fullItemName":"Scenario: Symptomatic treatment"},{"id":"36252764-f5e9-5b31-ad0b-ba291aef89e7","slug":"end-of-life-care","fullItemName":"Scenario: End of life care"},{"id":"350b3d29-e254-59ab-a297-4fad68eecad4","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"644dd5b8-ece9-502a-be3e-f0527653ac64","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bdaa86d3-a323-594c-b17f-71e8f0252c4c","slug":"nebulized-sodium-chloride","fullItemName":"Nebulized sodium chloride"},{"id":"b13d017f-af1d-5851-8c0e-967352e91bde","slug":"pholcodine-linctus-bp","fullItemName":"Pholcodine linctus BP"},{"id":"03f99c3c-08ce-5899-9fbe-4f57a0f2904f","slug":"codeine","fullItemName":"Codeine"},{"id":"60a78c3d-94b2-5e08-9e65-8bafd18725ba","slug":"morphine","fullItemName":"Morphine"},{"id":"45d8e905-93b4-585b-b370-12c26491e7e4","slug":"mucolytics","fullItemName":"Mucolytics"}]},{"id":"6c7c1d77-3b02-5361-979b-ceb31387e824","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"dd028d8e-6a48-5f6d-924a-d3970c3b0df9","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"26cda216-c628-5c3c-9604-cff1e8a0a730","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f586cb3d-0420-52a2-ac78-fd155050abc9","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9c55540f-e0ca-5527-8e1b-676719b74676","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"38ff8a0d-a949-566e-b696-ee543d5b835e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3f4f13e9-8e87-5cc5-b27e-0ef15bf0ac38","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b3492817-f33c-53f6-8da4-2144cd1afa9f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a8409825-4431-5ee0-9294-3c43a9596f99","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"a608510f-76fc-5e2f-9326-7e3d9b3ebfa9","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 7d69fd3d-93eb-4a0a-963b-8550f15f12f8 --><h3>Previous changes</h3><!-- end field 7d69fd3d-93eb-4a0a-963b-8550f15f12f8 -->","summary":null,"htmlStringContent":"<!-- begin item 6b5e27eb-36ce-435b-baf7-363bacf26535 --><!-- begin field c640332f-806b-4cc0-a87c-e461a02368e8 --><p><strong>July 2015 </strong>—<strong> </strong>topic title changed to reflect broader topic coverage than specifically cancer care.</p><p><strong>June 2015 </strong>— minor update. Based on an update to the manufacturer's Summary of Product Characteristics (SPC), vomiting has been included as a possible adverse effect of carbocisteine.</p><p><strong>April 2015 </strong>—<strong> </strong>minor update. Update to the text to reflect a new law on drugs and impaired driving.</p><p><strong>June 2013 </strong>— minor update. The 2013 QOF options for local implementation have been added to this topic.</p><p><strong>April 2013 </strong>— reviewed. A literature search was conducted in March 2013 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of this topic. No major changes to recommendations have been made.</p><p><strong>August 2012 </strong>— minor update. Minor typographical error corrected.</p><p><strong>March 2012 </strong>— minor update. The 2012/2013 QOF indicators have been added to this topic. Issued in April 2012.</p><p><strong>May 2011 </strong>— minor update. The 2011/2012 QOF indicators have been added to this topic. Issued in June 2011.</p><p><strong>February 2011 </strong>— topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made.</p><p><strong>December 2008 </strong>— minor typographical correction. Issued in January 2009.</p><p><strong>August 2007 </strong>— minor rewording to the Clinical Summaries.</p><p><strong>March to June 2007</strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There have been changes made to the recommendations regarding corticosteroid use. Also a new CKS topic covering general issues in palliative care has been written which replaces the general advice written in the previous CKS guidance.</p><p><strong>January 2006 </strong>— minor update. Prescriptions for diamorphine updated to reflect the change in handwriting requirements for controlled drug prescriptions. Issued in February 2006.</p><p><strong>October 2005 </strong>— minor technical update. Issued in November 2005.</p><p><strong>October 2003 </strong>— written. Validated in December 2003, and issued in February 2004.</p><!-- end field c640332f-806b-4cc0-a87c-e461a02368e8 --><!-- end item 6b5e27eb-36ce-435b-baf7-363bacf26535 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}